4 Biotech Stocks Most Wall Street Analysts Are Bullish About

Zacks Dec 20 01:30

Leerink Partners Maintains Alnylam Pharmaceuticals(ALNY.US) With Hold Rating

Futu NewsDec 18 14:32 · Ratings

Piper Sandler Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Raises Target Price to $304

Futu NewsDec 16 20:31 · Ratings

The Nasdaq 100 is about to adjust, and these 11 companies may see a 50% increase in upside potential.

As the annual adjustment of the NASDAQ 100 Index approaches, a group of potential stocks is preparing to make their debut. This adjustment not only brings prestige to these companies but may also trigger a large-scale inflow of capital, further driving up stock prices.

Golden10 DataDec 16 16:36

Alnylam Pharmaceuticals Insider Sold Shares Worth $439,760, According to a Recent SEC Filing

MT NewswiresDec 14 05:19

Palantir, MicroStrategy Could Be Added to Nasdaq 100 Friday. Moderna, Super Micro Could Be Dropped.

BarronsDec 14 00:46